May 9, 2017 / 12:58 PM / in 5 months

BRIEF-Abeona receives regulatory approval to start clinical trial in Australia

May 9 (Reuters) - Abeona Therapeutics Inc:

* Abeona Therapeutics receives regulatory approval to initiate clinical trial in Australia with ABO-102 gene therapy for patients with MPS IIIA

* Abeona Therapeutics receives regulatory approval to initiate clinical trial in Australia with ABO-102 gene therapy for patients with MPS IIIA

* Clinical study was approved by Australian government department of health therapeutic goods administration Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below